Literature DB >> 25622661

Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.

Ryusuke Imai1, Yukinori Takenaka, Toshimichi Yasui, Susumu Nakahara, Yoshifumi Yamamoto, Atsushi Hanamoto, Norihiko Takemoto, Takahito Fukusumi, Hironori Cho, Masashi Yamamoto, Hidenori Inohara.   

Abstract

CONCLUSIONS: Serum squamous cell carcinoma antigen (SCC-Ag) level was an independent prognostic factor for survival in patients with head and neck squamous cell carcinoma (HNSCC), and the prognostic value depended on the carcinoma site.
OBJECTIVES: To assess the value of SCC-Ag as a prognostic indicator in patients with HNSCC and to determine the effect of primary tumor site on prognosis.
METHODS: We reviewed 493 patients with HNSCC between 2004 and 2012. The chi-squared test was used to assess associations between SCC-Ag levels and TNM classification. A Cox proportional hazard model was used to assess the hazard ratio of SCC-Ag at different sites for death, and it was analyzed as a continuous variable.
RESULTS: The median serum level of SCC-Ag was 1.1 ng/ml (range 0-20). SCC-Ag was significantly higher in patients with advanced T and N classification tumors. Primary sites in the oral cavity, in the hypopharynx, advanced T and N classification, distant metastasis, and SCC-Ag were negatively associated with survival in univariate analysis. Multivariate analysis revealed that SCC-Ag was a significant risk factor for overall survival in cancers of the oral cavity, hypopharynx, and larynx, but not in oropharyngeal cancer.

Entities:  

Keywords:  Prognosis; hypopharynx; larynx; oral cavity; oropharynx; tumor marker

Mesh:

Substances:

Year:  2015        PMID: 25622661     DOI: 10.3109/00016489.2014.951454

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  10 in total

Review 1.  Squamous Cell Carcinoma Antigen: Clinical Application and Research Status.

Authors:  Huange Zhu
Journal:  Diagnostics (Basel)       Date:  2022-04-24

Review 2.  Distant metastasis from oral cavity-correlation between histopathology results and primary site.

Authors:  Yuka Uchiyama; Tadashi Sasai; Atsutoshi Nakatani; Hiroaki Shimamoto; Tomomi Tsujimoto; Sven Kreiborg; Shumei Murakami
Journal:  Oral Radiol       Date:  2020-05-28       Impact factor: 1.852

3.  Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma.

Authors:  Mohamad Adel; Chung-Kan Tsao; Fu-Chan Wei; Huei-Tzu Chien; Chih-Hsiung Lai; Chun-Ta Liao; Hung-Ming Wang; Kang-Hsing Fan; Chung-Jan Kang; Joseph Tung-Chieh Chang; Shiang-Fu Huang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.

Authors:  Yukinori Takenaka; Norihiko Takemoto; Toshimichi Yasui; Yoshifumi Yamamoto; Atsuhiko Uno; Haruka Miyabe; Naoki Ashida; Kotaro Shimizu; Susumu Nakahara; Atshushi Hanamoto; Takahito Fukusumi; Takahiro Michiba; Hironori Cho; Masashi Yamamoto; Hidenori Inohara
Journal:  PLoS One       Date:  2016-10-12       Impact factor: 3.240

5.  Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma.

Authors:  Xiu-Ping Tu; Qian-Hui Qiu; Liang-Si Chen; Xiao-Ning Luo; Zhong-Ming Lu; Si-Yi Zhang; Shao-Hua Chen
Journal:  BMC Cancer       Date:  2015-10-20       Impact factor: 4.430

6.  Evidence that circulating proteins are more promising than miRNAs for identification of patients with squamous cell carcinoma of the tongue.

Authors:  Linda Boldrup; Giuseppe Troiano; Xiaolian Gu; Philip Coates; Robin Fåhraeus; Torben Wilms; Lena Norberg-Spaak; Lixiao Wang; Karin Nylander
Journal:  Oncotarget       Date:  2017-09-30

7.  Nanodetection of Head and Neck Cancer on Titanium Oxide Sensing Surface.

Authors:  Yu Wang; Yan Guo; Jianguang Lu; Yanan Sun; Xiaoguang Yu; Subash C B Gopinath; Thangavel Lakshmipriya; Yuan Seng Wu; Chao Wang
Journal:  Nanoscale Res Lett       Date:  2020-02-03       Impact factor: 4.703

8.  Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.

Authors:  Sumitaka Hagiwara; Eiichi Sasaki; Yasuhisa Hasegawa; Hidenori Suzuki; Daisuke Nishikawa; Shintaro Beppu; Hoshino Terada; Michi Sawabe; Masahide Takahashi; Nobuhiro Hanai
Journal:  Cancer Med       Date:  2021-02-09       Impact factor: 4.452

9.  Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand.

Authors:  Chen-Tzu Chiu; Pei-Wen Wang; Meshach Asare-Werehene; Benjamin K Tsang; Dar-Bin Shieh
Journal:  Cancers (Basel)       Date:  2020-06-13       Impact factor: 6.639

10.  Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma.

Authors:  Hao Chen; Liru Tian; Jiahong Chen; Peng Sun; Runkun Han; Xingping Wu; Shuqin Dai
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.